大型网络内乳腺癌区域淋巴结照射计划质量审计:随机试验结果能否转化到临床实践
该研究审计了大型网络中183例淋巴结阳性乳腺癌患者的区域淋巴结照射(RNI)计划,评估区域淋巴结覆盖、勾画和剂量学参数与指南的依从性。结果显示虽然RNI指征依从性高,但18%的计划淋巴结未勾画或勾画质量不可接受,15%覆盖不足,提示常规临床实践需详细同行评审以转化试验结果。
要点
- 7.6%(14/183)患者虽有强烈指征但区域淋巴结未治疗。
- 18%计划淋巴结未勾画或勾画质量不可接受,15%覆盖不足。
- RNI患者中心脏平均剂量>4 Gy者3.1%,肺V20 Gy>35%者8.7%。
核心结论
- 区域淋巴结治疗指征依从性高,但勾画质量和覆盖不足可能削弱试验中3%–5%的无病生存获益。
研究设计与样本
- 回顾性审计大型网络中183例淋巴结阳性乳腺癌患者,评估RNI计划对指南的依从性。
主要发现
- 7.6%(14/183)有强烈指征但区域淋巴结未治疗,2.2%(4/183)未治疗任何淋巴结。
- 179例接受淋巴结照射者中,2.2%(4/179)治疗淋巴结未勾画,15.4%(27/175)勾画不可接受。
- 161例接受RNI者中,14.9%(24/161)靶区覆盖不足,3.1%(5/161)心脏平均剂量>4 Gy,8.7%(14/161)肺V20 Gy>35%。
关键数值与推荐
- RNI在两项大型随机试验中改善无病生存3%–5%,但依赖准确勾画和剂量递送。
- 心脏平均剂量>4 Gy和肺V20 Gy>35%被用作剂量学约束评估指标。
临床怎么用
- 常规临床实践需详细同行评审以识别勾画和覆盖偏差,确保试验结果转化。
局限性
- 原文未报告审计为回顾性设计、单网络数据,可能限制普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Regional nodal irradiation (RNI) improved disease-free survival by 3% to 5% in 2 large randomized trials, but this small absolute advantage relies on accurate contouring and dose delivery. We audited our network to determine compliance on regional nodal coverage, contouring, and dosimetric parameters with respect to accepted guidelines. METHODS AND MATERIALS: In our network, we have established a clinical pathway for patients with node-positive breast cancer that guides indications for RNI and dosimetric goals. We reviewed records of 183 patients with nodal macrometastases after upfront surgery or involved nodes of any size after neoadjuvant chemotherapy. Radiation treatment plans were examined to determine lymph node volumes treated, whether nodes were contoured, quality of nodal contours, and whether target coverage and normal organ dosimetric constraints were met when RNI was delivered. RESULTS: Despite the presence of macrometastases on sentinel lymph node biopsy, no lymph nodes were treated in 2.2% (4 of 183). Of 179 patients who received nodal irradiation, 18 received radiation to axillary levels 1 and 2 only, and 161 patients received RNI. Overall, regional nodes were not treated despite strong indications in 7.6% (14 of 183). Treated nodes were not contoured for 2.2% (4 of 179), and lymph node contours were unacceptable in 15.4% (27 of 175). Of patients receiving RNI, 14.9% (24 of 161) did not have adequate nodal target volume coverage, mean heart dose was >4 Gy for 3.1% (5 of 161), and lung V20 Gy was >35% for 8.7% (14 of 161). CONCLUSIONS: Adherence to indications for regional nodal treatment was high, but nodes were either not contoured or had unacceptable contour quality in 18% of plans, and coverage was inadequate in 15%. Because the small disease-free survival advantage seen in trials may be decreased with these deviations, routine clinical practice requires detailed peer review to fully translate results of clinical trials.
引用
- Ling DC, Moppins BL, Champ CE, et al. Quality of Regional Nodal Irradiation Plans in Breast Cancer Patients Across a Large Network-Can We Translate Results From Randomized Trials Into the Clinic? Pract Radiat Oncol. 2020. PMID: 32615162. doi:10.1016/j.prro.2020.06.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。